GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
H

Hyundai Bioscience Co 048410.KQ · KRW

Consumer Staples · KOSDAQ · 🇰🇷 South Korea

Compare

5,410

-4.08%

Close of 9 Nov 2026, in KRW

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in KRW, from our data supplier.

FY2025

Revenue

₩3.52bn

FY2016FY2025

Net income

−₩22.13bn

FY2016FY2025

Free cash flow

−₩37.24bn

FY2016FY2025

Shareholders' equity

₩110.73bn

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue₩3.52bn₩15.05bn₩9.48bn₩7.85bn₩9.24bn₩12.51bn₩30.09bn₩31.24bn₩31.97bn₩36.10bn
Research and development₩7.60bn₩3.06bn₩6.40bn₩16.46bn₩4.76bn₩1.97bn₩1.29bn₩1.70bn₩2.05bn₩2.11bn
Operating income−₩21.63bn₩791.0m−₩14.55bn−₩17.99bn−₩17.10bn−₩4.43bn₩2.56bn₩2.15bn₩1.46bn−₩6.96bn
Net income−₩22.13bn−₩6.93bn−₩14.50bn−₩15.81bn−₩20.05bn−₩8.61bn₩767.2m₩2.62bn₩1.22bn−₩8.07bn
Diluted earnings per share-230.41-87.01-364.25-398.36-518.69-239.6522.1578.3237.40-266.38

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assets₩130.74bn₩67.70bn₩52.79bn₩67.33bn₩80.53bn₩92.31bn₩63.24bn₩54.01bn₩49.50bn₩53.38bn
Cash and short-term investments———₩18.73bn₩22.20bn₩19.22bn₩7.06bn₩3.16bn₩4.85bn₩12.74bn
Total liabilities₩20.01bn₩28.27bn₩7.52bn₩9.09bn₩18.96bn₩41.09bn₩16.25bn₩13.52bn₩18.61bn₩35.17bn
Debt———₩6.25bn₩15.49bn₩37.14bn₩13.47bn₩9.27bn₩16.38bn₩27.32bn
Shareholders' equity₩110.73bn₩39.44bn₩45.27bn₩58.24bn₩61.57bn₩51.22bn₩46.99bn₩40.48bn₩30.89bn₩18.21bn
Shares outstanding96m80m40m40m39m36m35m33m33m30m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations−₩17.05bn₩2.26bn−₩6.01bn−₩16.54bn−₩538.5m₩7.50bn₩9.18bn₩5.01bn−₩3.70bn−₩4.34bn
Capital spending−₩20.19bn−₩2.17bn−₩587.5m−₩1.54bn−₩3.76bn−₩25.20bn−₩3.07bn−₩7.07bn−₩1.47bn−₩6.98bn
Free cash flow−₩37.24bn₩87.5m−₩6.60bn−₩18.09bn−₩4.30bn−₩17.70bn₩6.11bn−₩2.06bn−₩5.16bn−₩11.32bn

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
Revenue₩520.4m₩324.7m₩1.92bn₩553.1m₩332.9m₩708.8m₩365.5m₩458.7m
Operating income−₩5.96bn−₩5.15bn−₩4.50bn−₩4.62bn−₩4.80bn−₩5.42bn−₩3.63bn−₩4.32bn
Net income−₩11.56bn−₩5.31bn−₩4.74bn−₩7.00bn−₩4.25bn−₩6.14bn−₩4.56bn−₩5.13bn
Diluted earnings per share-119.78-55.05-49.35-72.86-44.28-63.92-57.25-60.67
Cash from operations−₩5.41bn−₩2.05bn−₩5.54bn−₩3.51bn−₩4.59bn−₩3.42bn₩2.26bn₩6.23bn
Capital spending——−₩442.0m—−₩18.91bn−₩845.0m−₩2.17bn−₩2.05bn
Free cash flow——−₩5.98bn—−₩23.50bn−₩4.26bn₩88.0m₩4.18bn
Total assets₩131.31bn₩129.10bn₩130.74bn₩116.62bn₩119.81bn₩142.39bn₩67.70bn₩70.97bn
Cash and short-term investments———————₩8.06bn
Debt₩6.26bn——————₩5.06bn
Shareholders' equity₩103.31bn₩111.98bn₩110.73bn₩110.28bn₩114.46bn₩117.53bn₩39.44bn₩43.74bn

Financial ratios

Data as of 29 Aug 2026

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Operating margin-614.8%5.3%-153.5%-229.1%-185.0%-35.4%———
Net margin-629.1%-46.0%-152.9%-201.3%-217.0%-68.8%———
Return on equity-20.0%-17.6%-32.0%-27.1%-32.6%-16.8%———
Return on assets-16.9%-10.2%-27.5%-23.5%-24.9%-9.3%———
Free cash flow yield——————5.5%5.6%-1.1%
Revenue growth-76.6%58.7%20.8%-15.0%-26.1%-58.4%———
Earnings growth219.3%-52.2%-8.3%-21.2%133.0%-1221.8%———
Current ratio2.25x0.25x2.18x2.86x2.09x4.37x———
Debt to equity———0.10x0.11x0.69x0.11x0.15x0.23x
Equity ratio84.7%58.3%85.8%86.5%76.5%55.5%———
Interest coverage-8.88x0.34x-46.27x-40.09x-5.69x-3.92x———
R&D as a share of sales215.9%20.3%67.5%209.6%51.5%15.7%———
Buybacks as a share of market value——————-3.6%-2.6%—

Growth per year

Compound annual rate

3 years5 years10 years
Revenue-23.5%-22.4%-21.7%
Operating income6.3%37.3%—
Net income11.9%20.8%—

Average margins

Over each period

1 year3 years5 years10 years
Operating margin-112.2%-148.7%-129.9%-32.6%
Net margin-156.5%-165.4%-152.7%-39.9%

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Price to earnings-21.6-81.1-33.7-32.4-22.9-57.3298.632.666.3-9.4
Price to sales135.637.351.665.249.739.57.62.72.52.1

Dividends and splits

Per share, in the currency the company pays

Paid for 0 years. Last went ex-dividend on 29 Dec 2003.

FY2004FY2003
Paid in the year3,533.3333,533.333
  • 2-for-1 split · 24 Jul 2025
  • 225-for-212 split · 17 Dec 2024
  • 10-to-1 reverse split · 9 Jan 2012
  • 30-to-1 reverse split · 21 Feb 2008
  • 2-for-1 split · 23 Apr 2004

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.